{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:35:24Z","timestamp":1786120524866,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54346-x","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:36:37Z","timestamp":1779957397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The SCD inhibitor MTI-301 reduces steatohepatitis and ratio of C18:1\/C18:0 levels in diet-induced murine models of MASH"],"prefix":"10.1038","volume":"16","author":[{"given":"Santhosh","family":"Shanthi Bhupathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar Reddy","family":"Kaulagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Eminhizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John A.","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhai","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devanand","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Maringa","family":"Githaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Geldenhuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Hazlehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"4","key":"54346_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77 (4), 1335\u20131347 (2023).","journal-title":"Hepatology"},{"issue":"6","key":"54346_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison, S. A. et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. N Engl. J. Med. 390 (6), 497\u2013509 (2024).","journal-title":"N Engl. J. Med."},{"issue":"21","key":"54346_CR3","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","volume":"392","author":"AJ Sanyal","year":"2025","unstructured":"Sanyal, A. J. et al. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. N Engl. J. Med. 392 (21), 2089\u20132099 (2025).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"54346_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40364-025-00765-3","volume":"13","author":"A Lin","year":"2025","unstructured":"Lin, A. et al. Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence. Biomark. Res. 13 (1), 50 (2025).","journal-title":"Biomark. Res."},{"issue":"2","key":"54346_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0952-3278(02)00261-2","volume":"68","author":"M Miyazaki","year":"2003","unstructured":"Miyazaki, M. & Ntambi, J. M. Role of stearoyl-coenzyme A desaturase in lipid metabolism. Prostaglandins Leukot. Essent. Fat. Acids. 68 (2), 113\u2013121 (2003).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"15","key":"54346_CR6","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1016\/S0021-9258(19)50107-7","volume":"267","author":"JM Ntambi","year":"1992","unstructured":"Ntambi, J. M. Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. J. Biol. Chem. 267 (15), 10925\u201310930 (1992).","journal-title":"J. Biol. Chem."},{"issue":"36","key":"54346_CR7","doi-asserted-by":"publisher","first-page":"33904","DOI":"10.1074\/jbc.M304724200","volume":"278","author":"M Miyazaki","year":"2003","unstructured":"Miyazaki, M. et al. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J. Biol. Chem. 278 (36), 33904\u201333911 (2003).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"54346_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1006\/geno.2000.6429","volume":"71","author":"Y Zheng","year":"2001","unstructured":"Zheng, Y. et al. Scd3\u2014A Novel Gene of the Stearoyl-CoA Desaturase Family with Restricted Expression in Skin. Genomics 71 (2), 182\u2013191 (2001).","journal-title":"Genomics"},{"issue":"3","key":"54346_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2005.05.013","volume":"332","author":"J Wang","year":"2005","unstructured":"Wang, J. et al. Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates. Biochem. Biophys. Res. Commun. 332 (3), 735\u2013742 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"54346_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4254\/wjh.v14.i1.168","volume":"14","author":"SM Jeyakumar","year":"2022","unstructured":"Jeyakumar, S. M. & Vajreswari, A. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. World J. Hepatol. 14 (1), 168\u2013179 (2022).","journal-title":"World J. Hepatol."},{"issue":"17","key":"54346_CR11","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1073\/pnas.0401627101","volume":"101","author":"P Dobrzyn","year":"2004","unstructured":"Dobrzyn, P. et al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc. Natl. Acad. Sci. U S A. 101 (17), 6409\u20136414 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"54346_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/gut.48.1.75","volume":"48","author":"T Gilat","year":"2001","unstructured":"Gilat, T. et al. Fatty acid bile acid conjugates (FABACs)--new molecules for the prevention of cholesterol crystallisation in bile. Gut 48 (1), 75\u201379 (2001).","journal-title":"Gut"},{"issue":"6","key":"54346_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.arcmed.2010.09.001","volume":"41","author":"A Leikin-Frenkel","year":"2010","unstructured":"Leikin-Frenkel, A. et al. Fatty acid bile acid conjugate inhibits hepatic stearoyl coenzyme A desaturase and is non-atherogenic. Arch. Med. Res. 41 (6), 397\u2013404 (2010).","journal-title":"Arch. Med. Res."},{"issue":"10","key":"54346_CR14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu, V. et al. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat. Med. 27 (10), 1825\u20131835 (2021).","journal-title":"Nat. Med."},{"issue":"3","key":"54346_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/HEP.0000000000000980","volume":"81","author":"V Ratziu","year":"2025","unstructured":"Ratziu, V. et al. Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. Hepatology 81 (3), 932\u2013946 (2025).","journal-title":"Hepatology"},{"issue":"1","key":"54346_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18632\/oncotarget.21545","volume":"9","author":"CA von Roemeling","year":"2018","unstructured":"von Roemeling, C. A. et al. Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy. Oncotarget 9 (1), 3\u201320 (2018).","journal-title":"Oncotarget"},{"issue":"6","key":"54346_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","volume":"6","author":"M Vacca","year":"2024","unstructured":"Vacca, M. et al. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD). Nat. Metabolism. 6 (6), 1178\u20131196 (2024).","journal-title":"Nat. Metabolism"},{"issue":"1","key":"54346_CR18","doi-asserted-by":"publisher","first-page":"22758","DOI":"10.1038\/s41598-023-49555-7","volume":"13","author":"J Martinez-Lomeli","year":"2023","unstructured":"Martinez-Lomeli, J. et al. Impact of various high fat diets on gene expression and the microbiome across the mouse intestines. Sci. Rep. 13 (1), 22758 (2023).","journal-title":"Sci. Rep."},{"issue":"7","key":"54346_CR19","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/biom15070990","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective. Biomolecules 15 (7), 990 (2025).","journal-title":"Biomolecules"},{"issue":"9","key":"54346_CR20","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/hep4.1107","volume":"1","author":"M Iruarrizaga-Lejarreta","year":"2017","unstructured":"Iruarrizaga-Lejarreta, M. et al. Role of Aramchol in steatohepatitis and fibrosis in mice. Hepatol. Commun. 1 (9), 911\u2013927 (2017).","journal-title":"Hepatol. Commun."},{"issue":"6","key":"54346_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (6), 1313\u20131321 (2005).","journal-title":"Hepatology"},{"issue":"1","key":"54346_CR22","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41467-021-23269-8","volume":"12","author":"JM Githaka","year":"2021","unstructured":"Githaka, J. M. et al. BAD regulates mammary gland morphogenesis by 4E-BP1-mediated control of localized translation in mouse and human models. Nat. Commun. 12 (1), 2939 (2021).","journal-title":"Nat. Commun."},{"issue":"29","key":"54346_CR23","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1038\/s41388-025-03420-1","volume":"44","author":"JM Githaka","year":"2025","unstructured":"Githaka, J. M. et al. Multiple anti-tumor programs are activated by blocking BAD phosphorylation. Oncogene 44 (29), 2530\u20132546 (2025).","journal-title":"Oncogene"},{"issue":"11","key":"54346_CR24","doi-asserted-by":"publisher","first-page":"105275","DOI":"10.1016\/j.jbc.2023.105275","volume":"299","author":"S Zhu","year":"2023","unstructured":"Zhu, S. et al. Proline provides a nitrogen source in the retinal pigment epithelium to synthesize and export amino acids for the neural retina. J. Biol. Chem. 299 (11), 105275 (2023).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"54346_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.apsb.2024.11.022","volume":"15","author":"Y Xia","year":"2025","unstructured":"Xia, Y. et al. Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders. Acta Pharm. Sin B. 15 (2), 892\u2013908 (2025).","journal-title":"Acta Pharm. Sin B"},{"issue":"2","key":"54346_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5625\/lar.2017.33.2.157","volume":"33","author":"SH Kim","year":"2017","unstructured":"Kim, S. H. et al. Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL\/6\u00a0N mice originating from three different sources. Lab. Anim. Res. 33 (2), 157\u2013164 (2017).","journal-title":"Lab. Anim. Res."},{"issue":"2","key":"54346_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1248\/bpb.b12-00702","volume":"36","author":"N Kurikawa","year":"2013","unstructured":"Kurikawa, N. et al. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. Biol. Pharm. Bull. 36 (2), 259\u2013267 (2013).","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"54346_CR28","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","volume":"152","author":"KKY Lai","year":"2017","unstructured":"Lai, K. K. Y. et al. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. Gastroenterology 152 (6), 1477\u20131491 (2017).","journal-title":"Gastroenterology"},{"issue":"35","key":"54346_CR29","doi-asserted-by":"publisher","first-page":"12501","DOI":"10.1073\/pnas.0503132102","volume":"102","author":"M Miyazaki","year":"2005","unstructured":"Miyazaki, M., Dobrzyn, A., Elias, P. M. & Ntambi, J. M. Stearoyl-CoA desaturase-2 gene expression is required for lipid synthesis during early skin and liver development. Proc. Natl. Acad. Sci. U S A. 102 (35), 12501\u201312506 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54346-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:41:10Z","timestamp":1786059670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54346-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54346"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54346-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Modulation Therapeutics has licensed MTI-301 and LAH is a cofounder and KH SK are employees at Modulation Therapeutics.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LAH is cofounder of Modulation Therapeutics and MTI-301 is licensed to Modulation Therapeutics. SK and KH are employees of Modulation Therapeutics.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were carried out in accordance with the National Institutes of Health guide for the care and use of Laboratory animals.","order":3,"name":"Ethics","label":"Compliance with Ethics Requirements","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24412"}}